Small and Medium-Sized Enterprises - Participation in FP7 projects in the Biotechnologies Activity

Small and Medium-Sized Enterprises - Participation in FP7 projects in the Biotechnologies Activity

This report provides a comprehensive and detailed overview of the very positive impact of the EU’s Seventh Framework Programme (FP7) on SMEs in this sector. It updates knowledge on SMEs’ profiles, share of funding received, their added value for projects, business benefits, etc. The positive results confirm that the European Commission’s efforts to support SME participation have paid off.


© European Union, 2014

Nachrichten unserer Mitglieder

  • BSB würdigt Symrise-Produkte SymGuard® CD und SymControlTM Care mit Innovationspreis

    Symrise AG 6.08.2018Mehr
  • MyBio Adopts Genedata for Improving Antibiotic Production Processes

    Genedata GmbH10.07.2018Mehr
  • Klaus Pellengahr neuer Geschäftsführer bei Organobalance-Novozymes Berlin. Gründerin Prof. Dr. Christine Lang bleibt dem Unternehmen als Beraterin verbunden

    Organobalance GmbH 2.07.2018Mehr
  • Alle Links